The Malta Independent 19 November 2026, Thursday
View E-Paper

The Malta Independent Online

Malta Independent Sunday, 29 October 2006, 00:00 Last update: about 21 years ago

There is an asymmetry between the cancer burden and the resources allocated to cancer care in Europe – the resources are inadequate and when available not efficiently used, said Professor Rifat Atun.

Prof. Atun is Professor of International Health Management at Imperial College London.

In his study titled “Burden of Cancer and Variations in Cancer Care in Europe: A Review of Published Literature”, Prof. Atun said that in 2004, there were an estimated 2.9 million new cancer cases in the 25 EU member States. In the same year, there were 1.7 million deaths from cancer – an increase of 600,000 from the level of 1.1 million deaths observed in 2000.

The World Health Organisation estimates that by 2020 the number of new cancer cases will increase by 25 per cent to reach 3.4 million, and the number of deaths from cancer in Europe will increase by 23 per cent to reach 2.1 million in 2020.

In Europe, the improvements in outcomes for cancer appear to be far below those enjoyed in the United States of America.

“We cannot say whether these differences are due to differences in data quality or if they are real,” the report said.

The improvements in cancer in Europe are below those achieved for improvements in cardiovascular disease.

He pointed out that there are cancer registries established in many of the EU member States but that the extent of the available data is limited.

Cancer registries help estimate the incidence, prevalence and burden of cancer and establish how outcomes are changing.

In Malta, cancer is diagnosed and treated at all levels of the health service. There is one cancer centre on the islands: the Oncology Department at Sir Paul Boffa Hospital. All radiotherapy and most chemotherapy are carried out in this department and all residents have access to the cancer treatment and rehabilitation services offered by this facility free of charge.

The Maltese National Cancer Registry (MNCR) covers the entire population and has been operating since 1991. All malignancies and most cancers are registered. Even though non-melanocytic skin carcinomas are registered, they are often excluded from general analyses of the cancer burden.

“However, we have limited data on how health systems in EU member States are responding to the prevailing cancer burden. We have limited information on the level of funding for cancer, whether these resources are allocated in an efficient manner, the effectiveness of the programmes provided, and the causes of the observed inequities.”

Prof. Atun said, “ It is difficult to see how EU member States can develop evidence-based policies to address the increasing cancer burden.”

He added that there are few agreed international benchmarks on the breadth and quality of services, which should be provided for cancer and that there is very limited data on the scope and quality of cancer services provided in Europe.

“While new innovative cancer medicines are used in Europe there are wide inequities in access to these innovative medicines. Different national approaches to pricing and for adoption of approved medicines onto reimbursement list lead to unacceptable delays in access.”

  • don't miss